Literature DB >> 18180502

Using an economic model of diabetes to evaluate prevention and care strategies in Australia.

Stephen Colagiuri1, Agnes E Walker.   

Abstract

The health benefits and costs of a national diabetes screening and prevention scenario are estimated among Australians ages 45-74. The Australian Diabetes Cost-Benefit Model is used to compare baseline and scenario outcomes from 2000 to 2010. Those newly diagnosed in 2000 receive intensive care, resulting in lower complication rates. People "at high risk" of developing diabetes are offered lifestyle intervention, reducing the numbers developing diabetes. A total of 115,000 people became "newly diagnosed." Among those deemed at high risk, 53,000 avoided developing diabetes by 2010. Average yearly intervention and incremental treatment cost was AU$179 million, with a cost per disability-adjusted life-year of AU$50,000.

Entities:  

Mesh:

Year:  2008        PMID: 18180502     DOI: 10.1377/hlthaff.27.1.256

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  12 in total

Review 1.  Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.

Authors:  Rui Li; Shuli Qu; Ping Zhang; Sajal Chattopadhyay; Edward W Gregg; Ann Albright; David Hopkins; Nicolaas P Pronk
Journal:  Ann Intern Med       Date:  2015-09-15       Impact factor: 25.391

2.  Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care.

Authors:  M Y Bertram; S S Lim; J J Barendregt; T Vos
Journal:  Diabetologia       Date:  2010-02-05       Impact factor: 10.122

3.  The Sydney Diabetes Prevention Program: a community-based translational study.

Authors:  Stephen Colagiuri; Philip Vita; Magnolia Cardona-Morrell; Maria Fiatarone Singh; Louise Farrell; Andrew Milat; Marion Haas; Adrian Bauman
Journal:  BMC Public Health       Date:  2010-06-10       Impact factor: 3.295

Review 4.  Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.

Authors:  Sanjib Saha; Ulf-G Gerdtham; Pia Johansson
Journal:  Int J Environ Res Public Health       Date:  2010-08-09       Impact factor: 3.390

5.  Screening with OGTT alone or in combination with the Indian diabetes risk score or genotyping of TCF7L2 to detect undiagnosed type 2 diabetes in Asian Indians.

Authors:  V Mohan; Jeremy D Goldhaber-Fiebert; V Radha; K Gokulakrishnan
Journal:  Indian J Med Res       Date:  2011-03       Impact factor: 2.375

6.  The impact of diabetes on the labour force participation, savings and retirement income of workers aged 45-64 years in Australia.

Authors:  Deborah Schofield; Michelle Cunich; Simon Kelly; Megan E Passey; Rupendra Shrestha; Emily Callander; Robert Tanton; Lennert Veerman
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

Review 7.  Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes.

Authors:  Samantha Roberts; Eleanor Barry; Dawn Craig; Mara Airoldi; Gwyn Bevan; Trisha Greenhalgh
Journal:  BMJ Open       Date:  2017-11-15       Impact factor: 2.692

8.  Are lifestyle interventions in primary care cost-effective?--An analysis based on a Markov model, differences-in-differences approach and the Swedish Björknäs study.

Authors:  Sanjib Saha; Katarina Steen Carlsson; Ulf-G Gerdtham; Margareta K Eriksson; Lars Hagberg; Mats Eliasson; Pia Johansson
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

9.  The impact of diabetes on the labour force participation and income poverty of workers aged 45-64 years in Australia.

Authors:  Deborah J Schofield; Michelle Cunich; Rupendra N Shrestha; Emily J Callander; Megan E Passey; Simon J Kelly; Robert Tanton; Lennert Veerman
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

Review 10.  The reality of type 2 diabetes prevention.

Authors:  Richard Kahn; Mayer B Davidson
Journal:  Diabetes Care       Date:  2014-04       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.